Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rolf Marschalek

Showing results (161-170 of 187) with videos related to

Pageof 19
Sort By:
Leukemia|March 23, 2024
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemiaThomas Burmeister, Aeint-Steffen Ströh, Britta Kehden, et al.
Cytogenetic and Genome Research|April 12, 2019
A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid LeukemiaRoberto R Capela de Matos, Daniela R Ney Garcia, Moneeb A K Othman, et al.
Hematological Oncology|June 11, 2016
Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypesDaniela R Ney Garcia, Mariana T de Souza, Amanda F de Figueiredo, et al.
Journal of Pediatric Hematology/Oncology|December 30, 2021
KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic LeukemiaRoberto R C de Matos, Gerson M Ferreira, Claus Meyer, et al.
Biomarker Research|July 29, 2025
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemiaOriol de Barrios, Ingrid Ocón-Gabarró, Mar Gusi-Vives, et al.
Cancer Genetics|May 25, 2021
Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosisIngrid Sardou-Cezar, Bruno A Lopes, Francianne Gomes Andrade, et al.
Haematologica|January 26, 2019
Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between <i>AF4-MLL</i> and <i>MLL-AF4</i> fusionsClara Bueno, Fernando J Calero-Nieto, Xiaonan Wang, et al.
Cellular and Molecular Life Sciences : CMLS|February 22, 2025
Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activitySarah Ciurus, Mohammed A F Elewa, Megan A Palmer, et al.
Molecular Oncology|August 1, 2012
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institutionNuno Cerveira, Susana Lisboa, Cecília Correia, et al.
Pediatric Blood & Cancer|February 27, 2021
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomabRosemary Sutton, Luciano Dalla Pozza, Seong Lin Khaw, et al.
Pageof 19

Showing results (161-170 of 187) with videos related to

Sort By:
Pageof 19
Leukemia|March 23, 2024
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemiaThomas Burmeister, Aeint-Steffen Ströh, Britta Kehden, et al.
Cytogenetic and Genome Research|April 12, 2019
A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid LeukemiaRoberto R Capela de Matos, Daniela R Ney Garcia, Moneeb A K Othman, et al.
Hematological Oncology|June 11, 2016
Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypesDaniela R Ney Garcia, Mariana T de Souza, Amanda F de Figueiredo, et al.
Journal of Pediatric Hematology/Oncology|December 30, 2021
KMT2A-MLLT1 and the Novel SEC16A-KMT2A in a Cryptic 3-Way Translocation t(9;11;19) Present in an Infant With Acute Lymphoblastic LeukemiaRoberto R C de Matos, Gerson M Ferreira, Claus Meyer, et al.
Biomarker Research|July 29, 2025
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemiaOriol de Barrios, Ingrid Ocón-Gabarró, Mar Gusi-Vives, et al.
Cancer Genetics|May 25, 2021
Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosisIngrid Sardou-Cezar, Bruno A Lopes, Francianne Gomes Andrade, et al.
Haematologica|January 26, 2019
Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between <i>AF4-MLL</i> and <i>MLL-AF4</i> fusionsClara Bueno, Fernando J Calero-Nieto, Xiaonan Wang, et al.
Cellular and Molecular Life Sciences : CMLS|February 22, 2025
Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activitySarah Ciurus, Mohammed A F Elewa, Megan A Palmer, et al.
Molecular Oncology|August 1, 2012
Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institutionNuno Cerveira, Susana Lisboa, Cecília Correia, et al.
Pediatric Blood & Cancer|February 27, 2021
Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomabRosemary Sutton, Luciano Dalla Pozza, Seong Lin Khaw, et al.
Pageof 19